Q32 Bio
QTTB
QTTB
62 hedge funds and large institutions have $20M invested in Q32 Bio in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 17 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
47% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 17
83% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 18
Holders
62
Holding in Top 10
–
Calls
$43K
Puts
$4K
Top Buyers
| 1 | +$144K | |
| 2 | +$131K | |
| 3 | +$63.8K | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$18.3K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$11.2K |
Top Sellers
| 1 | -$2.04M | |
| 2 | -$353K | |
| 3 | -$214K | |
| 4 |
BlackRock
New York
|
-$107K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$82K |